Tiziana Life Sciences Ltd (NASDAQ:TLSA) Financings
Financings
| Raise | Date |
|---|---|
| Registered direct offering of ordinary shares Closed: US$8.8M raised · US$1.25 a share · 1 warrant at US$1.5 Buyers: Ivor Elrifi (2,400,000 ordinary shares, bringing his total holding to 2,757,848 ordinary shares); Gabriele Cerrone (through Panetta Partners Ltd) (1,600,000 ordinary shares, bringing his total holdings to 44,974,830 ordinary shares) Insiders: Led by CEO Ivor Elrifi, who bought 2,400,000 shares; Executive Chairman Gabriele Cerrone bought 1,600,000 shares through Panetta Partners Ltd Use of proceeds: Complete Phase 2 na-SPMS and MSA clinical trials and achieve top line data readouts in both | Jan 16, 2026 |
| Public offering of common shares Cancelled: public offering | Dec 15, 2025 |